Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Jul 24;10(14):1468-1469.
doi: 10.1016/j.jcin.2017.06.004.

Reply: Duration of the Double Antiplatelet Therapy in Patients With Coronary and Peripheral Arterial Disease: The Key Might Be in the Type of Drug

Comment

Reply: Duration of the Double Antiplatelet Therapy in Patients With Coronary and Peripheral Arterial Disease: The Key Might Be in the Type of Drug

Eric A Secemsky et al. JACC Cardiovasc Interv. .

Comment on

Similar articles

See all similar articles

Substances

LinkOut - more resources

Feedback